WallStSmart

MDB Capital Holdings, LLC Class A common (MDBH)vsNomura Holdings Inc ADR (NMR)

VS

Smart Verdict

WallStSmart Research — data-driven comparison

Nomura Holdings Inc ADR generates 42569515% more annual revenue ($2.33T vs $5.48M). NMR leads profitability with a 17.3% profit margin vs 0.0%. NMR earns a higher WallStSmart Score of 84/100 (A-).

MDBH

Hold

35

out of 100

Grade: F

Growth: 5.3Profit: 4.5Value: 5.0Quality: 8.5
Piotroski: 3/9Altman Z: 10.55

NMR

Exceptional Buy

84

out of 100

Grade: A-

Growth: 10.0Profit: 7.0Value: 7.0Quality: 3.0
Piotroski: 4/9Altman Z: 0.53

Key Strengths & Concerns

Side-by-side fundamental analysis

Key Strengths

MDBH4 strengths · Avg: 10.0/10
Price/BookValuation
0.5x10/10

Reasonable price relative to book value

Operating MarginProfitability
1111.0%10/10

Strong operational efficiency at 1111.0%

Debt/EquityHealth
0.0110/10

Conservative balance sheet, low leverage

Altman Z-ScoreHealth
10.5510/10

Safe zone — low bankruptcy risk

NMR6 strengths · Avg: 9.0/10
Price/BookValuation
1.3x10/10

Reasonable price relative to book value

Operating MarginProfitability
30.8%10/10

Strong operational efficiency at 30.8%

Revenue GrowthGrowth
31.2%10/10

Revenue surging 31.2% year-over-year

PEG RatioValuation
0.828/10

Growing faster than its price suggests

P/E RatioValuation
12.8x8/10

Attractively priced relative to earnings

EPS GrowthGrowth
42.0%8/10

Earnings expanding 42.0% YoY

Areas to Watch

MDBH4 concerns · Avg: 3.3/10
EPS GrowthGrowth
0.0%4/10

0.0% earnings growth

Market CapQuality
$26.62M3/10

Smaller company, higher risk/reward

Profit MarginProfitability
0.0%3/10

0.0% margin — thin

Piotroski F-ScoreQuality
3/93/10

Weak financial health signals

NMR2 concerns · Avg: 1.5/10
Altman Z-ScoreHealth
0.532/10

Distress zone — elevated risk

Debt/EquityHealth
9.181/10

Elevated debt levels

Comparative Analysis Report

WallStSmart Research

Bull Case : MDBH

The strongest argument for MDBH centers on Price/Book, Operating Margin, Debt/Equity.

Bull Case : NMR

The strongest argument for NMR centers on Price/Book, Operating Margin, Revenue Growth. Profitability is solid with margins at 17.3% and operating margin at 30.8%. Revenue growth of 31.2% demonstrates continued momentum.

Bear Case : MDBH

The primary concerns for MDBH are EPS Growth, Market Cap, Profit Margin.

Bear Case : NMR

The primary concerns for NMR are Altman Z-Score, Debt/Equity. Debt-to-equity of 9.18 is elevated, increasing financial risk.

Key Dynamics to Monitor

MDBH profiles as a value stock while NMR is a growth play — different risk/reward profiles.

MDBH carries more volatility with a beta of 1.21 — expect wider price swings.

NMR is growing revenue faster at 31.2% — sustainability is the question.

Monitor CAPITAL MARKETS industry trends, competitive dynamics, and regulatory changes.

Bottom Line

NMR scores higher overall (84/100 vs 35/100), backed by strong 17.3% margins and 31.2% revenue growth. Both earn "Exceptional Buy" and "Hold" ratings respectively — the choice depends on your investment horizon and risk tolerance.

This analysis is generated from publicly available financial data. Not financial advice.

MDB Capital Holdings, LLC Class A common

FINANCIAL SERVICES · CAPITAL MARKETS · USA

MDB Capital Holdings, LLC (MDBH) is a forward-thinking investment firm that specializes in identifying and capitalizing on growth opportunities in the technology and life sciences sectors. With a seasoned management team at the helm, MDBH leverages strategic capital allocation and bespoke advisory services to maximize shareholder value and deliver robust returns for institutional investors. As a Class A common stock, MDBH is strategically positioned to navigate market fluctuations while committing to its mission of fostering innovation and financial integrity, thereby driving transformative growth in rapidly evolving industries.

Visit Website →

Nomura Holdings Inc ADR

FINANCIAL SERVICES · CAPITAL MARKETS · USA

Nomura Holdings, Inc. provides various financial services to individuals, corporations, financial institutions, governments, and government agencies worldwide. The company is headquartered in Tokyo, Japan.

Want to dig deeper into these stocks?